ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Water Immersion in Right-Sided Heart Failure: A Pilot Study

This study is currently recruiting participants.
Study NCT00654264.   Last updated on October 7, 2008.   Information provided by University of Maryland

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Water Immersion in Right-Sided Heart Failure: A Pilot Study
Official Title  Water Immersion in Right-Sided Heart Failure: A Pilot Study
Brief Summary

This is an unblinded pilot study comparing (against a randomized control day without water immersion) the diuretic and natriuretic effects of water immersion in patients with right heart failure.

Detailed Description

Patients will be immersed in a tub for 3 hours (on one day) and neurohormones will be obtained before and after immersion. Urine will be collected for quantification and evaluation of sodium concentration.

Study Phase Phase IV
Study Type  Interventional
Study Design  Treatment, Randomized, Open Label, Active Control, Crossover Assignment, Efficacy Study
Primary Outcome Measure  Diuresis [ Time Frame: 4 hours ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Neurohormonal activation [ Time Frame: 4 hours ] [ Designated as safety issue: No ]
Natriuresis [ Time Frame: 4 hours ] [ Designated as safety issue: No ]
Condition  Right Sided Cardiac Failure
Intervention  Procedure: Water immersion
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  13
Start Date  December 2007
Completion Date December 2009
Eligibility Criteria 

Inclusion Criteria:

  • Patients must have right sided failure secondary to right ventricular dysfunction, pulmonary hypertension, or tricuspid regurgitation
  • Age greater than 18 years of age
  • Right heart catheterization within the last year to rule out left-sided failure.
  • Evidence of fluid overload as indicated by 2 or more of the following: 1.) 2+ or more pitting edema of the lower extremities, 2.) scrotal or penile edema, 3.) JVP greater than or equal to 10 cm, 4.) abdominal ascites

Exclusion Criteria:

  • Pulmonary capillary wedge pressure above 16 mmHg or history of elevated left ventricular filling pressures.
  • Serum creatinine > 2.0
  • Current use of an angiotensin I converting enzyme inhibitor or angiotensin receptor blocker will preclude participation in the RAS neurohormone portion of the study.
Gender Both
Ages 18 Years and older
Accepts Healthy Volunteers No
Contacts ††
Contact: Stephen Gottlieb, MD     4103288788     sgottlie@medicine.umaryland.edu    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00654264
Organization ID H-29283
Secondary IDs ††
Study Sponsor  University of Maryland
Collaborators ††
Investigators 
Principal Investigator:     Stephen Gottlieb, MD     University of Maryland    
Information Provided By University of Maryland
Verification Date October 2008
First Received Date  April 1, 2008
Last Updated Date October 7, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers